Search Results - "STEWART, David B"

Refine Results
  1. 1

    Advances in therapeutic bacterial antisense biotechnology by Hegarty, John P., Stewart, David B.

    Published in Applied microbiology and biotechnology (01-02-2018)
    “…Antisense therapeutics are a biotechnological form of antibiotic therapy using chemical analogues of short single-stranded nucleic acid sequences modified to…”
    Get full text
    Journal Article
  2. 2

    ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections by Kelly, Colleen R., Fischer, Monika, Allegretti, Jessica R., LaPlante, Kerry, Stewart, David B., Limketkai, Berkeley N., Stollman, Neil H.

    Published in The American journal of gastroenterology (01-06-2021)
    “…Clostridioides difficile infection occurs when the bacterium produces toxin that causes diarrhea and inflammation of the colon. These guidelines indicate the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile by Hegarty, John P, Krzeminski, Jacek, Sharma, Arun K, Guzman-Villanueva, Diana, Weissig, Volkmar, Stewart, Sr, David B

    Published in International journal of nanomedicine (01-01-2016)
    “…Despite being a conceptually appealing alternative to conventional antibiotics, a major challenge toward the successful implementation of antisense treatments…”
    Get full text
    Journal Article
  9. 9

    Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study by Sangster, William, Hegarty, John P, Schieffer, Kathleen M, Wright, Justin R, Hackman, Jada, Toole, David R, Lamendella, Regina, Stewart, Sr, David B

    Published in Frontiers in microbiology (25-05-2016)
    “…This study sought to characterize the bacterial and fungal microbiota changes associated with Clostridium difficile infection (CDI) among inpatients with…”
    Get full text
    Journal Article
  10. 10

    Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection by Kulaylat, Audrey S, Buonomo, Erica L, Scully, Kenneth W, Hollenbeak, Christopher S, Cook, Heather, Petri, Jr, William A, Stewart, Sr, David B

    Published in JAMA surgery (01-12-2018)
    “…Recent evidence from an animal model suggests that peripheral loss of eosinophils in Clostridium difficile infection (CDI) is associated with severe disease…”
    Get more information
    Journal Article
  11. 11

    Phage tail-like particles kill Clostridium difficile and represent an alternative to conventional antibiotics by Sangster, William, MD, Hegarty, John P., PhD, Stewart, David B., MD, FACS, FASCRS

    Published in Surgery (01-01-2015)
    “…Background Current Clostridium difficile infection (CDI) antibiotic regimens have become increasingly ineffective at achieving cure and preventing recurrence…”
    Get full text
    Journal Article
  12. 12

    Cationic amphiphilic bolaamphiphile-based delivery of antisense oligonucleotides provides a potentially microbiome sparing treatment for C. difficile by Sharma, Arun K., Krzeminski, Jacek, Weissig, Volkmar, Hegarty, John P., Stewart, David B.

    Published in Journal of antibiotics (01-08-2018)
    “…Conventional antibiotics for C. difficile infection (CDI) have mechanisms of action without organismal specificity, potentially perpetuating the dysbiosis…”
    Get full text
    Journal Article
  13. 13

    Clostridioides difficile infection is associated with differences in transcriptionally active microbial communities by Chen See, Jeremy R, Leister, Jillian, Wright, Justin R, Kruse, Peter I, Khedekar, Mohini V, Besch, Catharine E, Kumamoto, Carol A, Madden, Gregory R, Stewart, David B, Lamendella, Regina

    Published in Frontiers in microbiology (2024)
    “…infection (CDI) is responsible for around 300,000 hospitalizations yearly in the United States, with the associated monetary cost being billions of dollars…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Determinants of 30-d readmission after colectomy by Kulaylat, Afif N., MD, Dillon, Peter W., MD, MSc, Hollenbeak, Christopher S., PhD, Stewart, David B., MD

    Published in The Journal of surgical research (01-02-2015)
    “…Abstract Background Readmission after colectomy has become an important metric for measuring quality of care. Our aim was to investigate the impact of patient…”
    Get full text
    Journal Article
  16. 16

    Correlation between virulence gene expression and proton pump inhibitors and ambient pH in Clostridium difficile: results of an in vitro study by STEWART, David B, HEGARTY, John P

    Published in Journal of medical microbiology (01-10-2013)
    “…Proton pump inhibitors (PPIs) are associated with the development of Clostridium difficile infection in humans. Though it is assumed that PPIs mediate this…”
    Get full text
    Journal Article
  17. 17

    Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus by Kulaylat, Audrey S, Hollenbeak, Christopher S, Stewart, David B

    Published in Diseases of the colon & rectum (01-09-2017)
    “…BACKGROUND:Squamous cell cancers of the anus are rare GI malignancies for which neoadjuvant chemoradiation is the first-line treatment for nonmetastatic…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection by Stewart, Sr, David B, Wright, Justin R, Fowler, Maria, McLimans, Christopher J, Tokarev, Vasily, Amaniera, Isabella, Baker, Owen, Wong, Hoi-Tong, Brabec, Jeff, Drucker, Rebecca, Lamendella, Regina

    Published in mSphere (28-08-2019)
    “…There has been no prior application of matched metagenomics and metatranscriptomics in infection (CDI) evaluating the role of fungi in CDI or identifying…”
    Get full text
    Journal Article